Comparison of the effect of liposomal clarithromycin plus glucantime and glucantime in treatment of cutaneous leishmaniasis
Phase 2
Recruiting
- Conditions
- leishmaniasis.Leishmaniasis
- Registration Number
- IRCT20171230038142N17
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Ages 15 to 65 years
Skin lesion with a diameter greater than 5 cm
Cartilage or articular or facial lesion
Number of lesions over 5 in patient
Leishmania's disease has been proven by the patient's Smear For Leishman Body Test.
Exclusion Criteria
Pregnant or lactating patients.
History of concurrent or previous treatment for the lesion.
Have heart, kidney, liver problems, drug side effects.
The patient's unwillingness.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The size of the lesion. Timepoint: Before, 6 weeks, 12 weeks and 6 months after intervention. Method of measurement: Physical examination.;Frequency of waste. Timepoint: Before, 6 weeks, 12 weeks and 6 months after intervention. Method of measurement: Physical examination.;Drug side effects. Timepoint: 6 weeks, 12 weeks and 6 months after intervention. Method of measurement: Physical examination.
- Secondary Outcome Measures
Name Time Method